• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

NeoGenomics Inc

+ Add to Watchlist


4.7400 USD 0.2300 4.63%

As of 20:10:00 ET on 10/20/2014.

Snapshot for NeoGenomics Inc (NEO)

Open: 5.0000 Day's Range: 4.7100 - 5.0500 Volume: 101,025
Previous Close: 4.9700 52wk Range: 2.8500 - 6.1000 1-Yr Rtn: +64.01%

Stock Chart for NEO

No chart data available.
  • NEO:US 4.7400
  • 1D
  • 1M
  • 1Y
Interactive NEO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NEO

Current P/E Ratio (ttm) 91.3154
Estimated P/E(12/2014) 948.0000
Relative P/E vs. SPX 5.3539
Earnings Per Share (USD) (ttm) 0.0519
Est. EPS (USD) (12/2014) 0.0050
Est. PEG Ratio 42.1333
Market Cap (M USD) 270.20
Shares Outstanding (M) 57.00
30 Day Average Volume 266,174
Price/Book (mrq) 10.2459
Price/Sale (ttm) 3.1556
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NEO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NEO

NeoGenomics, Inc. operates a network of clinical laboratories that specialize in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.

Douglas M VanoortChairman/CEOGeorge A CardozaChief Financial Officer
Robert J Shovlin "Rob"Chief Operating OfficerSteven A RossChief Information Officer
More Company Profile & Key Executives for NEO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil